Literature DB >> 25687595

Frontal P3 event-related potential is related to brain glutamine/glutamate ratio measured in vivo.

Mei-Hua Hall1, J Eric Jensen2, Fei Du3, Jordan W Smoller4, Lauren O'Connor5, Kevin M Spencer6, Dost Öngür5.   

Abstract

BACKGROUND: The auditory P3 event-related potential (ERP) is thought to index cognitive processing relevant to attention and working memory processes. Drug challenge studies suggest that glutamate neurotransmission plays an important role in modulating P3 ERP. However, while direct links between glutamate activity and P3 ERP response in humans are suspected, mechanistic details remain largely unknown. We investigated here the relationships between P3 ERP and indices of glutamatergic processing measured in vivo with proton magnetic resonance spectroscopy ((1)H MRS). We hypothesized that a higher index of glutamatergic processing (glutamine/glutamate ratio; abbreviated Gln/Glu) in the anterior cingulate (ACC) and in the parietal-occipital (POC) cortices would associate with larger frontal P3a and parietal P3b amplitudes, respectively.
METHODS: Frontal P3a (Fz) and parietal P3b (Pz) were collected from 32 healthy participants who performed an auditory oddball task. Resting glutamate (Glu), glutamine (Gln), and Gln/Glu (an index of glutamatergic processing) measures were obtained on a 4T MR scanner using J-resolved MR spectroscopy. Linear regression and partial correlations were used for statistical analysis.
RESULTS: Significant positive correlations were found between frontal P3a amplitude and ACC Gln/Glu ratio (partial R=0.57; P=0.001) and between frontal P3a amplitude and ACC Gln concentration (partial R=0.43; P=0.02). Relationships between parietal P3b and the glutamate indices in the POC were not significant.
CONCLUSIONS: These results indicate a specific connection between an index of glutamate neurotransmitter function in ACC and frontal P3 ERP, providing a novel insight into the neurochemistry underlying scalp recorded EEG response. Abnormalities in glutamate neurotransmission have been observed in schizophrenia and other psychiatric conditions and may underlie illness related deficits of P3 ERP.
Copyright © 2015 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Event-related potential; Glutamate; Magnetic resonance spectroscopy (MRS); P3

Mesh:

Substances:

Year:  2015        PMID: 25687595      PMCID: PMC4394009          DOI: 10.1016/j.neuroimage.2015.02.014

Source DB:  PubMed          Journal:  Neuroimage        ISSN: 1053-8119            Impact factor:   6.556


  39 in total

1.  Automatic quantitation of localized in vivo 1H spectra with LCModel.

Authors:  S W Provencher
Journal:  NMR Biomed       Date:  2001-06       Impact factor: 4.044

Review 2.  Neuroenergetics: calling upon astrocytes to satisfy hungry neurons.

Authors:  Luc Pellerin; Pierre J Magistretti
Journal:  Neuroscientist       Date:  2004-02       Impact factor: 7.519

Review 3.  From revolution to evolution: the glutamate hypothesis of schizophrenia and its implication for treatment.

Authors:  Bita Moghaddam; Daniel Javitt
Journal:  Neuropsychopharmacology       Date:  2011-09-28       Impact factor: 7.853

Review 4.  Role of astrocytes in glutamate homeostasis: implications for excitotoxicity.

Authors:  Arne Schousboe; Helle S Waagepetersen
Journal:  Neurotox Res       Date:  2005-11       Impact factor: 3.911

Review 5.  Updating P300: an integrative theory of P3a and P3b.

Authors:  John Polich
Journal:  Clin Neurophysiol       Date:  2007-06-18       Impact factor: 3.708

6.  Increased glutamine in patients undergoing long-term treatment for schizophrenia: a proton magnetic resonance spectroscopy study at 3 T.

Authors:  Juan R Bustillo; Hongji Chen; Thomas Jones; Nicholas Lemke; Christopher Abbott; Clifford Qualls; Jose Canive; Charles Gasparovic
Journal:  JAMA Psychiatry       Date:  2014-03       Impact factor: 21.596

7.  NMDA receptor and schizophrenia: a brief history.

Authors:  Joseph T Coyle
Journal:  Schizophr Bull       Date:  2012-09       Impact factor: 9.306

8.  Glutamatergic modulation of auditory information processing in the human brain.

Authors:  Handan Gunduz-Bruce; Robert M G Reinhart; Brian J Roach; Ralitza Gueorguieva; Stephen Oliver; Deepak C D'Souza; Judith M Ford; John H Krystal; Daniel H Mathalon
Journal:  Biol Psychiatry       Date:  2011-10-29       Impact factor: 13.382

9.  A new method for off-line removal of ocular artifact.

Authors:  G Gratton; M G Coles; E Donchin
Journal:  Electroencephalogr Clin Neurophysiol       Date:  1983-04

10.  Methionine sulfoximine, an inhibitor of glutamine synthetase, lowers brain glutamine and glutamate in a mouse model of ALS.

Authors:  Farhad Ghoddoussi; Matthew P Galloway; Amruta Jambekar; Monica Bame; Richard Needleman; William S A Brusilow
Journal:  J Neurol Sci       Date:  2010-01-08       Impact factor: 3.181

View more
  12 in total

Review 1.  Searching for Cross-Diagnostic Convergence: Neural Mechanisms Governing Excitation and Inhibition Balance in Schizophrenia and Autism Spectrum Disorders.

Authors:  Jennifer H Foss-Feig; Brendan D Adkinson; Jie Lisa Ji; Genevieve Yang; Vinod H Srihari; James C McPartland; John H Krystal; John D Murray; Alan Anticevic
Journal:  Biol Psychiatry       Date:  2017-03-14       Impact factor: 13.382

2.  Diabetes and the link between neuroplasticity and glutamate in the aging human motor cortex.

Authors:  Peter J Fried; Alvaro Pascual-Leone; Nicolas R Bolo
Journal:  Clin Neurophysiol       Date:  2019-06-21       Impact factor: 3.708

3.  A longitudinal study of event related potentials and correlations with psychosocial functioning and clinical features in first episode psychosis patients.

Authors:  Caitlin K Monaghan; Sophie Brickman; Polly Huynh; Dost Öngür; Mei-Hua Hall
Journal:  Int J Psychophysiol       Date:  2019-05-17       Impact factor: 2.997

4.  Frontal Glutamate and γ-Aminobutyric Acid Levels and Their Associations With Mismatch Negativity and Digit Sequencing Task Performance in Schizophrenia.

Authors:  Laura M Rowland; Ann Summerfelt; S Andrea Wijtenburg; Xiaoming Du; Joshua J Chiappelli; Nithin Krishna; Jeffrey West; Florian Muellerklein; Peter Kochunov; L Elliot Hong
Journal:  JAMA Psychiatry       Date:  2016-02       Impact factor: 21.596

5.  Effects of time-of-day on the concentration of defined excitatory and inhibitory amino acids in the cerebrospinal fluid of rats: a microdialysis study.

Authors:  Francisco Estrada-Rojo; Liliana Carmona-Aparicio; Virginia Arriaga-Avila; Elvia Coballase-Urrutia; Adán Pérez-Arredondo; Rosalinda Guevara-Guzmán; Noemi Cárdenas-Rodríguez; Luz Navarro
Journal:  Amino Acids       Date:  2021-08-30       Impact factor: 3.520

6.  Relationship between absolute and relative ratios of glutamate, glutamine and GABA and severity of autism spectrum disorder.

Authors:  Hanoof Al-Otaish; Laila Al-Ayadhi; Geir Bjørklund; Salvatore Chirumbolo; Mauricio A Urbina; Afaf El-Ansary
Journal:  Metab Brain Dis       Date:  2018-02-03       Impact factor: 3.584

7.  Transcutaneous Vagus Nerve Stimulation in Humans Induces Pupil Dilation and Attenuates Alpha Oscillations.

Authors:  Omer Sharon; Firas Fahoum; Yuval Nir
Journal:  J Neurosci       Date:  2020-11-19       Impact factor: 6.167

8.  Prolonged P300 Latency in Antipsychotic-Free Subjects with At-Risk Mental States Who Later Developed Schizophrenia.

Authors:  Yuko Higuchi; Tomiki Sumiyoshi; Takahiro Tateno; Suguru Nakajima; Daiki Sasabayashi; Shimako Nishiyama; Yuko Mizukami; Tsutomu Takahashi; Michio Suzuki
Journal:  J Pers Med       Date:  2021-04-21

9.  Conceptual convergence: increased inflammation is associated with increased basal ganglia glutamate in patients with major depression.

Authors:  E Haroon; C C Fleischer; J C Felger; X Chen; B J Woolwine; T Patel; X P Hu; A H Miller
Journal:  Mol Psychiatry       Date:  2016-01-12       Impact factor: 15.992

10.  "Brain MR spectroscopy in autism spectrum disorder-the GABA excitatory/inhibitory imbalance theory revisited".

Authors:  Maiken K Brix; Lars Ersland; Kenneth Hugdahl; Renate Grüner; Maj-Britt Posserud; Åsa Hammar; Alexander R Craven; Ralph Noeske; C John Evans; Hanne B Walker; Tore Midtvedt; Mona K Beyer
Journal:  Front Hum Neurosci       Date:  2015-06-22       Impact factor: 3.169

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.